Skip to content
ppharmaranks
Menu

Best treatments for pheochromocytoma

4 products may treat pheochromocytoma, spanning FDA drug classes such as beta-adrenergic blocker, catecholamine synthesis inhibitor. The current highest-rated option is inderal la. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 4 drugs we list for pheochromocytoma, 3 are available as lower-cost generics, spanning classes such as beta-adrenergic blocker, catecholamine synthesis inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for pheochromocytoma — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 15, 2026·How we rate

Top-rated picks for pheochromocytoma: 1. Inderal La · 2. Innopran XL · 3. Demser

Top-rated treatments for pheochromocytoma, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$2View →
270/100$2View →
3Not yet ratedView →
4Not yet rated$2View →

Full ranking · 4 treatments

Frequently asked

What treats pheochromocytoma?
Our catalog lists 4 products that may treat pheochromocytoma, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is inderal la.
What is the best-rated treatment for pheochromocytoma?
By our independent recall-safety rating — not an efficacy measure — inderal la ranks highest among the products we list for pheochromocytoma. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat pheochromocytoma?
Treatments for pheochromocytoma span FDA drug classes including beta-adrenergic blocker, catecholamine synthesis inhibitor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.